Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Stent Placement on Survival in Patients with Malignant Portal Vein Stenosis: A Propensity Score-Matched Study

  • Dong Jae Shim (Department of Radiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Jong Woo Kim (Department of Radiology, Chung-Ang University Health Care System, Hyundae Hospital) ;
  • Doyoung Kim (Department of Radiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Gi-Young Ko (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Dong Il Gwon (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Ji Hoon Shin (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Yun-Jung Yang (Institute of Biomedical Science, Catholic Kwandong University International St. Mary's Hospital)
  • Received : 2021.04.14
  • Accepted : 2021.09.24
  • Published : 2022.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Percutaneous portal vein (PV) stent placement can be an effective treatment for symptoms associated with portal hypertension. This study aimed to evaluate the effect of PV stenting on the overall survival (OS) in patients with malignant PV stenosis. Materials and Methods: Two groups of patients with malignant PV stenosis were compared in this retrospective study involving two institutions. A total of 197 patients who underwent PV stenting between November 2016 and August 2019 were established as the stent group, whereas 29 patients with PV stenosis who were treated conservatively between July 2013 and October 2016 constituted the no-stent group. OS was compared between the two groups before and after propensity score matching (PSM). Risk factors associated with OS were evaluated using the Cox proportional hazards model. Procedure-associated adverse events were also evaluated. Results: The stent group finally included 100 patients (median age, 65 [interquartile range, 58-71] years; 64 male). The no-stent group included 22 patients (69 [61-75] years, 13 male). Stent placement was successful in 95% of attempted cases, and the 1- and 2-year stent occlusion-free survival rate was 56% (95% confidence interval, 45%-69%) and 44% (32%-60%), respectively. The median stent occlusion-free survival time was 176 (interquartile range, 70-440) days. OS was significantly longer in the stent group than in the no-stent group (median 294 vs. 87 days, p < 0.001 before PSM, p = 0.011 after PSM). The 1- and 3-year OS rates before PSM were 40% and 11%, respectively, in the stent group. The 1-year OS rate after PSM was 32% and 5% in the stent and no-stent groups, respectively. Anemia requiring transfusion (n = 2) and acute thrombosis necessitating re-stenting (n = 1) occurred in three patients in the stent group within 1 week. Conclusion: Percutaneous placement of a PV stent may be effective in improving OS in patients with malignant PV stenosis.

Keywords

References

  1. Park JH, Yeo JH, Kim YS, Ahn HK, Sym S, Shin D, et al. Portal vein stent for symptomatic malignant portal vein stenosis: a single-center experience. Curr Probl Cancer 2020;44:100476 
  2. Sakurai K, Amano R, Yamamoto A, Nishida N, Matsutani S, Hirata K, et al. Portal vein stenting to treat portal vein stenosis in a patient with malignant tumor and gastrointestinal bleeding. Int Surg 2014;99:91-95 
  3. Jeon UB, Kim CW, Kim TU, Choo KS, Jang JY, Nam KJ, et al. Therapeutic efficacy and stent patency of transhepatic portal vein stenting after surgery. World J Gastroenterol 2016;22:9822-9828 
  4. Shim DJ, Shin JH, Ko GY, Kim Y, Han K, Gwon DI, et al. Portal vein stent placement with or without varix embolization of jejunal variceal bleeding after hepatopancreatobiliary surgery. Acta Radiol 2017;58:423-429 
  5. Sheth RA, Sabir SH, Parmet P, Amin R, Kuban JD, Huang SY, et al. Portomesenteric venous stenting for palliation of ascites and variceal bleeding caused by prehepatic portal hypertension. Oncologist 2018;23:712-718 
  6. Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, et al. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-516 
  7. Lee JH, Yoon CJ, Choi WS. Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure. Eur Radiol 2021;31:1300-1307 
  8. Novellas S, Denys A, Bize P, Brunner P, Motamedi JP, Gugenheim J, et al. Palliative portal vein stent placement in malignant and symptomatic extrinsic portal vein stenosis or occlusion. Cardiovasc Intervent Radiol 2009;32:462-470 
  9. Hasegawa T, Yamakado K, Takaki H, Nakatsuka A, Uraki J, Yamanaka T, et al. Portal venous stent placement for malignant portal venous stenosis or occlusion: who benefits? Cardiovasc Intervent Radiol 2015;38:1515-1522 
  10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213 
  11. Heyne JP, Pfleiderer SO, Trebing G, Scheele J, Kaiser WA. Palliative portal vein stent placement for lymphatic recurrence of gastric cancer. Int J Colorectal Dis 2005;20:67-71 
  12. Shirata C, Nishioka Y, Sato J, Watadani T, Arita J, Akamatsu N, et al. Therapeutic effect of portal vein stenting for portal vein stenosis after upper-abdominal surgery. HPB (Oxford) 2020;23:238-244 
  13. Matsumura K, Hashimoto D, Umezaki N, Nakagawa S, Chikamoto A, Yamashita Y, et al. Hepatobiliary and pancreatic: portal vein stent for local recurrence of bile duct cancer. J Gastroenterol Hepatol 2017;32:1425 
  14. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol 1990;1:17-22 
  15. Watanabe Y, Sato M, Abe Y, Ueda S, Kashu H, Nakamura Y, et al. Metallic stents for low invasive recanalization of the portal veins with cancerous invasion--first case report. Hepatogastroenterology 1998;45:551-553 
  16. Yamazaki S, Kuramoto K, Itoh Y, Watanabe Y, Susa N, Ueda T. Clinical significance of portal venous metallic stent placement in recurrent periampullary cancers. Hepatogastroenterology 2005;52:191-193 
  17. Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Terada N, Takeda K. Malignant portal venous obstructions treated by stent placement: significant factors affecting patency. J Vasc Interv Radiol 2001;12:1407-1415 
  18. Kyriazanos ID, Tsoukalos GG, Papageorgiou G, Verigos KE, Miliadis L, Stoidis CN. Local recurrence of pancreatic cancer after primary surgical intervention: how to deal with this devastating scenario? Surg Oncol 2011;20:e133-e142 
  19. Khan A, Kleive D, Aandahl EM, Fosby B, Line PD, Dorenberg E, et al. Portal vein stent placement after hepatobiliary and pancreatic surgery. Langenbecks Arch Surg 2020;405:657-664